Nature's Sunshine Products (NATR) vs Entrada Therapeutics (TRDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Entrada Therapeutics (TRDA) has outperformed Nature's Sunshine Products (NATR) over the past year, losing 4.1% versus a loss of 16.8%. Nature's Sunshine Products is the larger company by market cap ($220.3 million vs $211.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NATR | TRDA |
|---|---|---|
| Share price | $12.52 | $5.44 |
| Market cap | $220.30M | $211.62M |
| 1-day change | -0.56% | -3.12% |
| YTD return | -41.66% | -45.43% |
| 1-year return | -16.79% | -4.10% |
| 5-year return | -18.09% | — |
| P/E ratio (TTM) | 12.40 | — |
| Forward P/E | 10.18 | — |
| EPS (TTM) | $1.01 | $-3.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.14 | $16.45 |
| 52-week low | $12.31 | $5.15 |
| Distance from 52-week high | -55.51% | -66.96% |
| Analyst consensus | none | none |
| Avg. price target upside | +143.61% | +249.59% |
| Average volume | 159.62K | 359.01K |
| Shares outstanding | 17.60M | 38.94M |
| Employees | 806 | 152 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TRDA has outperformed NATR by 12.7 percentage points over the past year.
About Nature's Sunshine Products
NATR stock →Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees
About Entrada Therapeutics
TRDA stock →Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 152 employees
NATR vs TRDA FAQ
Which is bigger, Nature's Sunshine Products or Entrada Therapeutics?
Nature's Sunshine Products (NATR) is larger, with a market capitalization of $220.30M compared with $211.62M for Entrada Therapeutics (TRDA).
Which stock has performed better over the past year, NATR or TRDA?
TRDA returned -4.10% over the past 12 months, compared with -16.79% for NATR (price return, excluding dividends). Past performance does not predict future results.
Are Nature's Sunshine Products and Entrada Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.